Dr. Sandy Srinivas explains how age, comorbidities and medications influence personalized prostate cancer treatment decisions ...

Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual ...

MacDonald draws on her unique dual perspective to advocate for better patient education. Despite a decade of medical ...

Most surgical candidates, including many with prior thoracic or abdominal operations, can undergo minimally invasive ...

In this segment, Ms. Popolo discusses the practical and logistical differences between intravenous and subcutaneous ...

Receiving a diagnosis of stage 1 urothelial carcinoma (bladder cancer) can feel overwhelming, but at this stage, the cancer ...

Dr. Bizekis emphasized that ongoing heartburn should not be ignored. For patients with persistent reflux, speaking with a doctor and considering further evaluation, such as an endoscopy, can help ...

Meetings like SGO drive collaboration and patient-centered progress, as Dr. Ginger J. Gardner highlights their role in advancing access and research.

Attending meetings like the SGO Annual Meeting on Women's Cancer is driven by a shared commitment to patients and advancing ...

Testicular cancer awareness messaging should target men aged 15–35 and emphasize that early detection materially improves ...

Rapid diagnostic-to-treatment trajectories in young adults intensify trauma, disrupt schooling, and amplify unmet needs around identity, cognition, neuropathy, and reintegration into age-normative ...

Daraxonrasib delivered a median overall survival of 13.2 months versus 6.7 months with standard chemotherapy in previously ...